ArticleRespiratory research2023

Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study.

Alessandra Vultaggio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.